Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -36.63%5.76B | -37.48%9.08B | 67.18%14.53B | 286.05%8.69B | -67.47%2.25B | -37.96%6.92B | 33.66%11.15B | -52.82%8.35B | -39.72%17.69B | -39.23%29.34B |
Net profit before non-cash adjustment | -43.48%7.17B | -13.05%12.69B | 8.96%14.6B | 122.15%13.4B | 9.04%6.03B | -18.95%5.53B | -16.91%6.82B | -6.49%8.21B | 341.36%8.78B | -93.41%1.99B |
Total adjustment of non-cash items | 120.65%96M | 54.37%-465M | 49.58%-1.02B | 18.54%-2.02B | -337.42%-2.48B | -71.02%1.05B | 3,155.93%3.61B | -102.31%-118M | -78.15%5.11B | 71.66%23.4B |
-Depreciation and amortization | 3.31%343M | -46.19%332M | -24.39%617M | 13.97%816M | -21.92%716M | -33.69%917M | -33.51%1.38B | 21.57%2.08B | -66.31%1.71B | -27.34%5.08B |
-Reversal of impairment losses recognized in profit and loss | --0 | 55.56%56M | 176.92%36M | -95.52%13M | -27.86%290M | -87.24%402M | -23.30%3.15B | 261.85%4.11B | -96.77%1.14B | 710.98%35.16B |
-Disposal profit | -120.99%-72M | 102.96%343M | 106.01%169M | 14.81%-2.81B | -445.62%-3.3B | 27.02%-605M | 67.59%-829M | -357.60%-2.56B | 93.44%-559M | -1,801.60%-8.53B |
-Net exchange gains and losses | -106.18%-567M | 80.77%-275M | -1,886.11%-1.43B | -5.88%-72M | -187.18%-68M | -61.76%78M | 108.36%204M | -156.31%-2.44B | 149.66%4.34B | -1,045.54%-8.73B |
-Other non-cash items | 142.56%392M | -124.09%-921M | -1,308.82%-411M | 128.81%34M | -146.64%-118M | 183.77%253M | 76.88%-302M | 13.51%-1.31B | -471.92%-1.51B | -84.17%406M |
Changes in working capital | 51.92%-1.51B | -431.96%-3.15B | 135.28%948M | -106.85%-2.69B | -482.06%-1.3B | -52.84%340M | 188.40%721M | -93.41%250M | -4.07%3.79B | -11.01%3.95B |
-Change in receivables | 139.79%267M | -1,056.90%-671M | 70.41%-58M | 74.84%-196M | -292.82%-779M | 45.32%404M | 151.39%278M | -110.85%-541M | -49.72%4.99B | -24.97%9.92B |
-Change in prepaid assets | 116.29%57M | -114.14%-350M | 241.35%2.48B | -21.18%-1.75B | -2,508.33%-1.45B | --60M | ---- | ---- | ---- | ---- |
-Change in payables | 195.91%539M | -192.28%-562M | 7,712.50%609M | -101.34%-8M | 5,860.00%596M | -98.95%10M | 173.34%949M | 22.14%-1.29B | 70.57%-1.66B | 29.93%-5.65B |
-Provision for loans, leases and other losses | 1,100.00%90M | 89.77%-9M | 54.87%-88M | -149.62%-195M | 19,750.00%393M | 99.88%-2M | -245.51%-1.72B | 119.33%1.18B | 268.65%538M | 55.57%-319M |
-Changes in other current assets | -58.59%-2.47B | 21.86%-1.56B | -270.58%-1.99B | -739.06%-537M | 51.52%-64M | -110.90%-132M | 33.81%1.21B | 1,356.94%905M | ---72M | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -76.14%-155M | -72.55%-88M | -104.00%-51M | -25M | 0 | -1M | 0 | 0 | 90.38%-5M | 59.06%-52M |
Interest received (cash flow from operating activities) | -50.56%133M | 572.50%269M | -55.06%40M | 11.25%89M | 1,900.00%80M | -98.81%4M | 28.24%336M | 571.79%262M | -11.36%39M | 29.41%44M |
Tax refund paid | 52.25%-2.23B | -127.56%-4.67B | -22.41%-2.05B | -463.09%-1.68B | -188.96%-298M | 114.18%335M | -177.57%-2.36B | 129.72%3.05B | -32.30%-10.25B | 43.70%-7.74B |
Other operating cash inflow (outflow) | 0 | 0 | 428.26%755M | -22,900.00%-230M | -1M | 0 | -1M | 0 | 0 | -1M |
Operating cash flow | -23.70%3.5B | -65.27%4.59B | 93.08%13.22B | 236.91%6.85B | -72.00%2.03B | -20.48%7.26B | -21.67%9.13B | 55.86%11.65B | -65.37%7.48B | -37.31%21.59B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 67.83%-138M | 68.22%-429M | -2,600.00%-1.35B | 83.33%-50M | 73.71%-300M | -158.73%-1.14B | -258.54%-441M | 1.60%-123M | 32.80%-125M | 15.45%-186M |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | 14.13%-79M | 76.83%-92M | -649.06%-397M | 92.56%-53M | 79.00%-712M |
Net business purchase and sale | -58.51%39M | 0.00%94M | -27.69%94M | --130M | ---- | 270.51%370M | 96.72%-217M | -2,512.25%-6.61B | 81.40%-253M | ---1.36B |
Net investment product transactions | 92.71%-88M | 69.81%-1.21B | -197.18%-4B | 93.60%4.11B | 167.33%2.13B | -49.57%-3.16B | -69.21%-2.11B | -913.82%-1.25B | -103.19%-123M | 1,007.29%3.86B |
Dividends received (cash flow from investment activities) | ---- | ---- | ---- | ---- | 284.01%2.35B | -44.02%613M | 47.38%1.1B | -52.16%743M | 86.43%1.55B | -55.22%833M |
Net changes in other investments | -85.13%164M | 2,551.11%1.1B | -295.65%-45M | -8.00%23M | 113.66%25M | -101.10%-183M | 81.50%-91M | 81.26%-492M | -211.89%-2.63B | 339.39%2.35B |
Investing cash flow | 94.76%-23M | 91.72%-439M | -225.66%-5.3B | 0.31%4.22B | 217.56%4.2B | -92.67%-3.58B | 77.16%-1.86B | -399.69%-8.13B | -134.04%-1.63B | 251.41%4.78B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -87.01%1B | --7.7B | --0 | --7.96B | ---- | ---- | ---- | 98.47%-25M | 83.16%-1.64B | -3.36%-9.72B |
Net common stock issuance | --0 | 93.08%-2.41B | -261.48%-34.89B | -594.32%-9.65B | 53.85%-1.39B | ---3.01B | ---- | -41.75%60M | 104.40%103M | -1,025.69%-2.34B |
Cash dividends paid | -0.15%-1.97B | 25.29%-1.97B | -15.86%-2.64B | 1.13%-2.28B | 30.22%-2.3B | -27.67%-3.3B | -37.89%-2.58B | 19.67%-1.87B | 9.96%-2.33B | 19.81%-2.59B |
Net other fund-raising expenses | 50.00%-26M | -842.86%-52M | 115.91%7M | 25.42%-44M | 60.14%-59M | -190.24%-148M | 8,100.00%164M | -93.55%2M | 19.23%31M | 2,500.00%26M |
Financing cash flow | -130.61%-999M | 108.70%3.26B | -834.86%-37.52B | -6.98%-4.01B | 41.93%-3.75B | -166.90%-6.46B | -31.74%-2.42B | 52.12%-1.84B | 73.77%-3.84B | -18.13%-14.63B |
Net cash flow | ||||||||||
Beginning cash position | 11.51%74.29B | -29.74%66.62B | 8.97%94.82B | 3.01%87.02B | -3.12%84.47B | 5.84%87.2B | 2.73%82.38B | 1.43%80.19B | 22.40%79.06B | 42.06%64.59B |
Current changes in cash | -66.55%2.48B | 125.05%7.42B | -519.82%-29.6B | 183.70%7.05B | 189.49%2.49B | -157.25%-2.78B | 187.04%4.85B | -16.05%1.69B | -82.84%2.01B | -37.90%11.73B |
Effect of exchange rate changes | 104.37%515M | -81.97%252M | 1,841.67%1.4B | 18.03%72M | 15.09%61M | 247.22%53M | -107.38%-36M | 147.61%488M | -156.76%-1.03B | 678.45%1.81B |
Cash adjustments other than cash changes | ---- | 300.00%2M | -100.15%-1M | --684M | ---- | ---- | -107.14%-1M | -90.14%14M | -84.75%142M | 93,200.00%931M |
End cash Position | 4.03%77.29B | 11.51%74.29B | -29.74%66.62B | 8.97%94.82B | 3.01%87.02B | -3.12%84.47B | 5.84%87.2B | 2.73%82.38B | 1.43%80.19B | 22.40%79.06B |
Free cash flow | -19.15%3.36B | -64.94%4.16B | 74.63%11.87B | 292.38%6.8B | -71.32%1.73B | -29.74%6.04B | -22.80%8.59B | 52.53%11.13B | -64.72%7.3B | -32.88%20.69B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |